Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.9800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.0000/ 45
- Ask / Lots4.0800/ 5
- Open / Previous Close0.0000 / 3.9800
- Day Range---
- 52 Week Range
- Volume1,968
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 8031 | 3.875 |
| 09:34 ET | 16105 | 3.78 |
| 09:36 ET | 21550 | 3.795 |
| 09:38 ET | 2090 | 3.79 |
| 09:39 ET | 19774 | 3.7564 |
| 09:41 ET | 10324 | 3.765 |
| 09:43 ET | 6853 | 3.7901 |
| 09:45 ET | 39345 | 3.7857 |
| 09:48 ET | 6900 | 3.78 |
| 09:50 ET | 3893 | 3.79 |
| 09:52 ET | 7885 | 3.78 |
| 09:54 ET | 1173 | 3.761 |
| 09:56 ET | 4714 | 3.76 |
| 09:57 ET | 4164 | 3.78 |
| 09:59 ET | 3902 | 3.78 |
| 10:01 ET | 23928 | 3.815 |
| 10:03 ET | 23869 | 3.812 |
| 10:06 ET | 12595 | 3.835 |
| 10:08 ET | 11678 | 3.81 |
| 10:10 ET | 2950 | 3.805 |
| 10:12 ET | 3404 | 3.815 |
| 10:14 ET | 700 | 3.805 |
| 10:15 ET | 10426 | 3.8 |
| 10:17 ET | 1599 | 3.809 |
| 10:19 ET | 1008 | 3.81 |
| 10:21 ET | 1598 | 3.8 |
| 10:24 ET | 300 | 3.8 |
| 10:26 ET | 3596 | 3.815 |
| 10:28 ET | 2300 | 3.825 |
| 10:30 ET | 200 | 3.82 |
| 10:32 ET | 2350 | 3.81 |
| 10:33 ET | 600 | 3.8 |
| 10:35 ET | 200 | 3.805 |
| 10:37 ET | 2200 | 3.81 |
| 10:39 ET | 2603 | 3.815 |
| 10:42 ET | 6899 | 3.805 |
| 10:44 ET | 200 | 3.8 |
| 10:46 ET | 500 | 3.8 |
| 10:48 ET | 200 | 3.8 |
| 10:50 ET | 400 | 3.805 |
| 10:51 ET | 11002 | 3.8 |
| 10:53 ET | 1403 | 3.79 |
| 10:55 ET | 800 | 3.79 |
| 10:57 ET | 1300 | 3.78 |
| 11:00 ET | 25046 | 3.725 |
| 11:02 ET | 16502 | 3.7771 |
| 11:04 ET | 2800 | 3.77 |
| 11:06 ET | 7932 | 3.75 |
| 11:08 ET | 3800 | 3.76 |
| 11:09 ET | 3298 | 3.76 |
| 11:11 ET | 1776 | 3.77 |
| 11:13 ET | 452 | 3.775 |
| 11:15 ET | 1200 | 3.77 |
| 11:18 ET | 500 | 3.77 |
| 11:20 ET | 10800 | 3.77 |
| 11:22 ET | 3350 | 3.785 |
| 11:24 ET | 100 | 3.78 |
| 11:26 ET | 526 | 3.78 |
| 11:27 ET | 16352 | 3.78 |
| 11:29 ET | 9616 | 3.81 |
| 11:31 ET | 343 | 3.8 |
| 11:33 ET | 1400 | 3.8062 |
| 11:36 ET | 1726 | 3.8 |
| 11:38 ET | 1800 | 3.81 |
| 11:40 ET | 1297 | 3.805 |
| 11:42 ET | 8381 | 3.8 |
| 11:45 ET | 1426 | 3.8 |
| 11:47 ET | 5635 | 3.82 |
| 11:49 ET | 4108 | 3.81 |
| 11:51 ET | 1352 | 3.81 |
| 11:54 ET | 2000 | 3.8 |
| 11:56 ET | 2427 | 3.795 |
| 11:58 ET | 1526 | 3.8 |
| 12:00 ET | 11780 | 3.8 |
| 12:02 ET | 1650 | 3.805 |
| 12:03 ET | 4500 | 3.81 |
| 12:05 ET | 500 | 3.805 |
| 12:07 ET | 1491 | 3.805 |
| 12:09 ET | 10927 | 3.82 |
| 12:12 ET | 2982 | 3.8245 |
| 12:14 ET | 758 | 3.825 |
| 12:16 ET | 8246 | 3.825 |
| 12:18 ET | 200 | 3.825 |
| 12:21 ET | 818 | 3.825 |
| 12:23 ET | 5091 | 3.845 |
| 12:25 ET | 7916 | 3.865 |
| 12:27 ET | 300 | 3.86 |
| 12:30 ET | 38865 | 3.88 |
| 12:32 ET | 15637 | 3.8825 |
| 12:34 ET | 5118 | 3.9 |
| 12:36 ET | 2826 | 3.895 |
| 12:38 ET | 1185 | 3.895 |
| 12:39 ET | 1670 | 3.895 |
| 12:41 ET | 20703 | 3.9 |
| 12:43 ET | 700 | 3.905 |
| 12:45 ET | 11699 | 3.93 |
| 12:48 ET | 7869 | 3.92 |
| 12:50 ET | 4368 | 3.925 |
| 12:52 ET | 4418 | 3.925 |
| 12:54 ET | 400 | 3.925 |
| 12:56 ET | 1118 | 3.925 |
| 12:57 ET | 1100 | 3.925 |
| 12:59 ET | 1900 | 3.915 |
| 01:01 ET | 2336 | 3.915 |
| 01:03 ET | 400 | 3.915 |
| 01:06 ET | 400 | 3.91 |
| 01:08 ET | 600 | 3.915 |
| 01:10 ET | 1910 | 3.925 |
| 01:12 ET | 3700 | 3.925 |
| 01:14 ET | 2749 | 3.915 |
| 01:15 ET | 1000 | 3.915 |
| 01:17 ET | 1100 | 3.91 |
| 01:19 ET | 318 | 3.905 |
| 01:21 ET | 1877 | 3.9211 |
| 01:24 ET | 818 | 3.915 |
| 01:26 ET | 500 | 3.915 |
| 01:28 ET | 500 | 3.915 |
| 01:30 ET | 11243 | 3.93 |
| 01:32 ET | 700 | 3.93 |
| 01:33 ET | 1500 | 3.93 |
| 01:35 ET | 1300 | 3.92 |
| 01:37 ET | 600 | 3.9225 |
| 01:39 ET | 9715 | 3.935 |
| 01:42 ET | 5100 | 3.935 |
| 01:44 ET | 2700 | 3.935 |
| 01:46 ET | 1131 | 3.935 |
| 01:48 ET | 1371 | 3.935 |
| 01:50 ET | 600 | 3.935 |
| 01:51 ET | 450 | 3.94 |
| 01:53 ET | 2018 | 3.935 |
| 01:55 ET | 3255 | 3.935 |
| 01:57 ET | 1018 | 3.93 |
| 02:00 ET | 1800 | 3.93 |
| 02:02 ET | 16193 | 3.95 |
| 02:04 ET | 35026 | 3.95 |
| 02:06 ET | 2936 | 3.925 |
| 02:08 ET | 26026 | 3.925 |
| 02:09 ET | 19119 | 3.925 |
| 02:11 ET | 100 | 3.925 |
| 02:13 ET | 1500 | 3.925 |
| 02:15 ET | 11301 | 3.925 |
| 02:18 ET | 800 | 3.925 |
| 02:20 ET | 3754 | 3.935 |
| 02:22 ET | 400 | 3.93 |
| 02:24 ET | 600 | 3.93 |
| 02:26 ET | 200 | 3.9225 |
| 02:27 ET | 2100 | 3.945 |
| 02:29 ET | 2923 | 3.925 |
| 02:31 ET | 3000 | 3.935 |
| 02:33 ET | 2665 | 3.925 |
| 02:36 ET | 400 | 3.925 |
| 02:38 ET | 3637 | 3.925 |
| 02:40 ET | 4698 | 3.925 |
| 02:42 ET | 9336 | 3.93 |
| 02:44 ET | 600 | 3.925 |
| 02:45 ET | 900 | 3.925 |
| 02:47 ET | 624 | 3.925 |
| 02:49 ET | 1400 | 3.925 |
| 02:51 ET | 4870 | 3.93 |
| 02:54 ET | 300 | 3.925 |
| 02:56 ET | 1701 | 3.925 |
| 02:58 ET | 2900 | 3.925 |
| 03:00 ET | 4064 | 3.93 |
| 03:02 ET | 5113 | 3.93 |
| 03:03 ET | 1600 | 3.94 |
| 03:05 ET | 1800 | 3.94 |
| 03:07 ET | 1593 | 3.9471 |
| 03:09 ET | 1703 | 3.94 |
| 03:12 ET | 5874 | 3.945 |
| 03:16 ET | 1100 | 3.93 |
| 03:18 ET | 600 | 3.935 |
| 03:20 ET | 28183 | 3.94 |
| 03:21 ET | 5700 | 3.945 |
| 03:23 ET | 2393 | 3.945 |
| 03:25 ET | 2237 | 3.93 |
| 03:27 ET | 1696 | 3.935 |
| 03:30 ET | 5270 | 3.925 |
| 03:32 ET | 700 | 3.915 |
| 03:34 ET | 2462 | 3.91 |
| 03:36 ET | 2432 | 3.915 |
| 03:38 ET | 1767 | 3.9125 |
| 03:39 ET | 9512 | 3.93 |
| 03:41 ET | 12656 | 3.935 |
| 03:43 ET | 8696 | 3.92 |
| 03:45 ET | 8047 | 3.93 |
| 03:48 ET | 11859 | 3.9568 |
| 03:50 ET | 2209 | 3.955 |
| 03:52 ET | 10129 | 3.975 |
| 03:54 ET | 12914 | 3.985 |
| 03:56 ET | 8968 | 3.995 |
| 03:57 ET | 25431 | 3.975 |
| 03:59 ET | 17848 | 3.98 |
Jun 20, 2024
DJ Mereo BioPharma Group Is Maintained at Outperform by Leerink Partners, from 8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 14, 2024
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow JonesPress Release: Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 13, 2024
DJ Mereo BioPharma Group Initiated at Outperform by Baird, from 5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 608.1M | -12.7x | --- |
Immunome Inc | 746.0M | -2.3x | --- |
Mesoblast Ltd | 778.7M | -4.9x | --- |
Stoke Therapeutics Inc | 741.7M | -5.9x | --- |
Dianthus Therapeutics Inc | 749.3M | -8.0x | --- |
Nuvation Bio Inc | 753.9M | -9.7x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $608.1M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 152.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-0.31 |
Book Value | $0.44 |
P/E Ratio | -12.7x |
Price/Sales (TTM) | 60.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
